Healthcare -
Biotechnology - NASDAQ - US
$ 1.68
-8.7 %
$ 125 M
Market Cap
-1.45
P/E
IKT - GROSS PROFIT
Gross Profit IKT - Inhibikase Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR